Content area

|
|

Sentinel node-positivt melanom

Forfatter(e)
Mette Haldrup1, Lars B. Stolle1, Lisbet Rosenkrantz Hölmich2 & Annette Chakera2 1) Plastikkirurgisk Afdeling, Aarhus Universitetshospital2) Plastikkirurgisk Afdeling, Herlev Hospital

Ugeskr Læger 2018;180:V03180192
Reference: 
Ugeskr Læger 2018;180:V03180192
Sidetal: 

Mette Haldrup, Lars B. Stolle, Lisbet Rosenkrantz Hölmich
& Annette Chakera:

Sentinel node-positive melanoma

Ugeskr Læger 2018;180:V03180192

Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Erik Jakob Møller | 15/12
12 kommentarer
af Trine Cecilie Jeppesen | 15/12
1 Kommentar
af Lars Linnet | 14/12
1 Kommentar
af Niels Ejnar Bie | 14/12
1 Kommentar
af John Erik Bleibach | 14/12
1 Kommentar
af Mogens Stubkjær Hüttel | 14/12
35 kommentarer
af Lene Vejen Christiansen | 13/12
3 kommentarer
af Christian F. Asmussen | 13/12
7 kommentarer